Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Diabetes & Metabolism Journal
>
2011
>
35
>
3
Volume:
35
Issue:
3
1. Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration.
Page:290—297
2. Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus.
Page:282—289
3. Small Rice Bowl-Based Meal Plan for Energy and Marcronutrient Intake in Korean Men with Type 2 Diabetes: A Pilot Study.
Page:273—281
4. Therapeutic Target Achievement in Type 2 Diabetic Patients after Hyperglycemia, Hypertension, Dyslipidemia Management.
Page:264—272
5. Prevalence of Diabetes Mellitus and Prediabetes in Dalseong-gun, Daegu City, Korea.
Page:255—263
6. Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease.
Page:248—254
7. Angiotensin II Inhibits Insulin Binding to Endothelial Cells.
Page:243—247
8. The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension.
Page:236—242
9. Comparison of EGF with VEGF Non-Viral Gene Therapy for Cutaneous Wound Healing of Streptozotocin Diabetic Mice.
Page:226—235
10. ATP-Sensitive Potassium Channel-Deficient Mice Show Hyperphagia but Are Resistant to Obesity.
Page:219—225
11. Chemerin: A Novel Link between Inflammation and Atherosclerosis?.
Page:216—218
12. Mitochondrial Dysfunction and Insulin Resistance: The Contribution of Dioxin-Like Substances.
Page:207—215
13. Clinical Allogeneic and Autologous Islet Cell Transplantation: Update.
Page:199—206
14. Diabetes and Cancer: Is Diabetes Causally Related to Cancer?.
Page:193—198
15. Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65).
Page:300—301
16. Letter: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65).
Page:298—299
